Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin

References

• Akagi T, Watanabe K, Kim H, Akashi M. Stabilization of polyion complex nanoparticles composed of poly (amino acid) using hydrophobic interactions. Langmuir, 2010;26:2406–13
   PubMed Web of Science ®Google Scholar
• Aoki Y, Morishita M, Asai K, Akikusa B, Hosoda S, Takayama K. Region dependent role of the mucous glycocalyx layers in insulin permeation across rat small intestinal membrane. Pharm Pharm Res, 2005a;22:1854–6
   PubMed Web of Science ®Google Scholar
• Aoki Y, Morishita M, Takayama K. Role of the mucus/glycocalyx layers in insulin permeation across the rat ileal membrane. Int J Pharm, 2005b;297:98–109
   PubMed Web of Science ®Google Scholar
• Bakhru SH, Furtado S, Morello AP, Mathiowitz E. Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev, 2013;65:811–21
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Kast CE. Chemically modified chitosans as enzyme inhibitors. Adv Drug Deliv Rev, 2001;52:127–37
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release, 1998;52:1–16
   PubMed Web of Science ®Google Scholar
• Boshuizen JA, Reimerink JHJ, Korteland-van Male AM, van Ham VJJ, Bouma J, Gerwig GJ, Koopmans MPG, Buller HA, Dekker J, Einerhand AWC. Homeostasis and function of goblet cells during rotavirus infection in mice. Virology, 2005;337:210–21
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y. In vitro and in vivo study of n-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm, 2008;349:226–33
   PubMed Web of Science ®Google Scholar
• Chen M, Mi F, Liao Z, Hsiao C, Sonaje K, Chung M, Hsu L, Sung H. Recent advance in nanocarrier-based mucosal delivery of biomolecules. Adv Drug Deliv Rev, 2013;65:865–79
   PubMed Web of Science ®Google Scholar
• Chen J, Sun X, Song Z, Huang Y. Synthesis of camostat derivative. West China J Pharm Sci, 2015;2015:5–7
   Google Scholar
• Chuang E, Lin K, Su F, Chen H, Maiti B, Ho YC, Yen TC, Panda N, Sung HW. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery. J Control Release, 2013a;169:296–305
   PubMed Web of Science ®Google Scholar
• Chuang E, Lin K, Su F, Mi F, Maiti B, Chen CT, Wey SP, Yen TC, Juang JH, Sung HW. Noninvasive imaging oral absorption of insulin delivery by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats. J Control Release, 2013b;172:513–22
   PubMed Web of Science ®Google Scholar
• Deshmukh DD, Ravia WR, Betageri GV. Improved delivery of cromolyn from oral proliposomal beads. Int J Pharm, 2008;358:128–36
   PubMed Web of Science ®Google Scholar
• Fix JA. Oral controlled release technology for peptides: Status and future prospects. Pharm Res, 1996;13:1760–4
   PubMed Web of Science ®Google Scholar
• Fortuna A, Alves G, Falcao A, Soares-da-Silva P. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique. Epilepsia, 2012;53(3):529–38
   PubMed Web of Science ®Google Scholar
• Ikesue K, Kopeckova P, Kopecek J. Degradation of proteins by guinea pig intestinal enzymes. Int J Pharm, 1993;95:171–9
   Web of Science ®Google Scholar
• Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials, 2012a;33:1573–82
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhou D, Yang HY, Zhu X, Wang XR, Zhang ZR. Effect of degree of quaternization on the preparation and characterization of insulin-loaded trimethyl chitosan polyelectrolyte complexes optimized by central composite design. Pharm Dev Technol, 2012b;17:719–29
   PubMed Web of Science ®Google Scholar
• Jin Y. 2012. Trimethyl chitosan chitosan chloride nanoparticles with targeting modification and stability modification for the oral delivery of insulin [Dissertation]. Chengdu: Sichuan University
   Google Scholar
• Jintapattanakit A, Kissel T, Buraphacheep JV. Effect of tripolyphosphate on physical and enzymatic stabilities of insulin loaded nanoparticles of N-trimethyl chitosan. Mahidol Univ J Pharm Sci, 2008;35:1–7
   Google Scholar
• Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: A concise review. Nanomedicine Nanotechnol Biol Med, 2005;1:193–212
   PubMed Web of Science ®Google Scholar
• Langguth P, Bohner V, Heizmann J, Merkle HP, Wolffram S, Amidon GL, Yamashita S. The challenge of proteolytic enzymes in intestinal peptide delivery. J. Control Release, 1997;46:39–57
   Web of Science ®Google Scholar
• Leppert PS, Fix JA. Use of everted intestinal rings for in vitro examination of aral absorption potential. J Pharm Sci, 1994;83:976–81
   PubMed Web of Science ®Google Scholar
• Lian H, Zhang T, Sun J, Liu X, Ren G, Kou L, Zhang Y, Han X, Ding W, Ai X, et al. Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol Pharm, 2013;10:3447–58
   PubMed Web of Science ®Google Scholar
• Lin YH, Sonaje K, Lin KM, Juang JH, Mi FL, Yang HW, Sung HW. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release, 2008;132:141–9
   PubMed Web of Science ®Google Scholar
• Liu B, Meng Z. Advances of synthetic serine protease inhibitors. Chin J New Drugs, 2006;15:334–6
   Google Scholar
• Molina AJ, Merino G, Prieto JG, Real R, Mendoza G, Alvarez AI. Absorption and metabolism of albendazole after intestinal ischemia/reperfusion. Eur J Pharm Sci, 2007;31:16–24
   PubMed Web of Science ®Google Scholar
• Rozehnal V, Nakai D, Hoepner U, Fischer T, Kamiyama E, Takahashi M, Yasuda S, Mueller J. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. Eur J Pharm Sci, 2012;46:367–73
   PubMed Web of Science ®Google Scholar
• Saffran M, Kumar G, Savariar C, Burnham J, Williams F, Neckers D. A new approach to the oral administration of insulin and other peptide drugs. Science, 1986;233:1081–4
   PubMed Web of Science ®Google Scholar
• Schilling RJ, Mitra AK. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm Res, 1991;8:721–7
   PubMed Web of Science ®Google Scholar
• Schmidt C, Lautenschlaeger C, Collnot EM, Schumann M, Bojarski C, Schulzke JD, Lehr CM, Stallmach A. Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa – A first in vivo study in human patients. J Control Release, 2013;165:139–45
   PubMed Web of Science ®Google Scholar
• Sioberg A, Lutz M, Tannergren C, Wingolf C, Borde A, Ungell AL. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Eur J Pharm Sci, 2013;48:166–80
   PubMed Web of Science ®Google Scholar
• Su F, Lin K, Sonaje K, Wey S, Yen TC, Ho YC, Panda N, Chuang EY, Maiti B, Sung HW. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials, 2012;33:2801–11
   PubMed Web of Science ®Google Scholar
• Woodley JF. Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst, 1994;11:61–95
   PubMed Web of Science ®Google Scholar
• Yin L, Ding J, He C, Cui L, Tang C, Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials, 2009;30:5671–700
   Google Scholar
• Yun Y, Cho YW, Park K. Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands. Adv Drug Deliv Rev, 2013;65:822–32
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhu X, Jin Y, Shan W, Huang Y. Mechanism study of cellular uptake and tight junctions opening mediated by goblet cell-specific trimethyl chitosan nanoparticles. Mol Pharm, 2014;5:1520–32
   Web of Science ®Google Scholar
• Zhiwen Z, Huihui B, Zhiwei G, Yan H, Fang G, Yaping L. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm, 2010;394:147–53
   PubMed Web of Science ®Google Scholar